CAS 6168-76-9

Crotethamide

Description:

Crotethamide, with the CAS number 6168-76-9, is a chemical compound that belongs to the class of amides. It is primarily recognized for its use in the pharmaceutical industry, particularly as a local anesthetic. The compound exhibits characteristics typical of amides, including the presence of a carbonyl group (C=O) bonded to a nitrogen atom (N). Crotethamide is known for its ability to block nerve conduction, making it effective in pain management applications. Its chemical structure contributes to its solubility and stability under various conditions. Additionally, it may possess specific pharmacokinetic properties that influence its absorption, distribution, metabolism, and excretion in biological systems. Safety and toxicity profiles are essential considerations in its application, and regulatory guidelines govern its use in medicinal formulations. Overall, crotethamide serves as an important compound in therapeutic contexts, particularly in procedures requiring localized pain relief.

Formula: C₁₂H₂₂N₂O₂

InChI: InChI=1S/C12H22N2O2/c1-6-9-11(15)14(8-3)10(7-2)12(16)13(4)5/h6,9-10H,7-8H2,1-5H3

InChI key: InChIKey=LSAMUAYPDHUBQD-UHFFFAOYSA-N

SMILES: C(N(C(C=CC)=O)CC)(C(N(C)C)=O)CC

Synonyms:

• (2E)-N-[1-(dimethylcarbamoyl)propyl]-N-ethylbut-2-enamide
• 2-Butenamide, N-[1-[(dimethylamino)carbonyl]propyl]-N-ethyl-
• Crotethamid
• Crotethamide
• Crotonamide, N-[1-(dimethylcarbamoyl)propyl]-N-ethyl-
• Ethylbutamide
• N-(1-dimethylcarbamoylpropyl)-N-ethylcrotonamide
• N-[1-(dimethylamino)-1-oxobutan-2-yl]-N-ethylbut-2-enamide
• N-[1-[(Dimethylamino)carbonyl]propyl]-N-ethyl-2-butenamide
• α-(N′-Crotonyl-N′-ethylamino)-N,N-dimethylbutyramide

Crotethamide

CAS: 6168-76-9

Formula: C₁₂H₂₂N₂O₂

Ref: TR-TRC-C818500

Crotethamide

Controlled Product

CAS: 6168-76-9

Formula: C₁₂H₂₂N₂O₂

Color and Shape: Neat

Molecular weight: 226.32

Ref: TR-C818500

N-[1-(Dimethylcarbamoyl)propyl]-N-ethyl-but-2-enamide

Controlled Product

CAS: 6168-76-9

Sodium citrate is an antimicrobial agent that inhibits the growth of bacteria by producing water vapor and fatty acid. It also has a biocompatible polymer and glutamate, which are components for the production of nanoparticulate compositions. These compositions have been shown to have a positive effect on chronic bronchitis, bowel disease, and congestive heart failure. Sodium citrate may also be used as a control agent in analysis of inflammatory bowel disease.

Formula: C₁₂H₂₂N₂O₂

Purity: Min. 95%

Color and Shape: Clear Viscous Liquid

Molecular weight: 226.32 g/mol

Ref: 3D-FD156959